Thursday, April 17, 2014 4:36:29 PM
Apr 25th 12:00 pm - 1:00 pm
Room 3320, Faculty of Pharmaceutical Sciences - 2405 Wesbrook Mall, Vancouver, BC
Details:
Genomic data have become commonplace in most branches of the biological sciences and have fundamentally altered the way research is conducted.
However, the predominance of high-throughput, short-read sequence data from second-generation technologies has commonly resulted in fragmented and partial genomic and transcriptomic data, limiting the type of genetic variation able to be characterized. Long, unbiased reads from SMRT sequencing now allow for a return to more contiguous and comprehensive views of genomes and transcriptomes.
I will present several examples highlighting this transition, including improved de novo genome assemblies, characterizing structural genetic diversity, and resolving previously unsequenceable genomic regions. In the area of RNA-seq, I will highlight numerous examples of full-length transcript recall and splice isoform characterization in human and other complex transcriptomes that demonstrate that the identification of transcript isoforms and even gene content is far from complete.
Speaker Bio:
Luke Hickey is Director of Marketing and Business Development at Pacific Biosciences. He has 15 years of experience in the genome technology industry, holding various R&D, Marketing and Commercial roles at Pacific Biosciences, Affymetrix, Ingenuity Systems, and Incyte Genomics.
He currently leads development of applied markets for PacBio’s single molecule long read sequencing technology. In this role, he has contributed to co-developing novel methods and applications of the technology resulting in numerous high impact publications, including; Sequencing of the Fragile X gene, full length transcript isoform sequencing, compound somatic mutation phasing, gene editing outcome profiling, long read de novo assembly methods (HGAP/Quiver), human structural variation sequencing, centromere sequencing, haplotype phasing, and methylation profiling for epigenetic analysis.
He is on the steering committee for the 100k Pathogen project, an active participant in the NIST Genome in a Bottle Initiative, the 1,000 Genome Project, and a member of Toastmasters International. He is based in San Francisco, California with his wife and three children.
Date and Location:
Date: Friday, April 25th, 2014.
Time: 12pm - 1pm
Location: Room 3320, Faculty of Pharmaceutical Sciences. 2405 Wesbrook Mall, Vancouver, BC.
http://www.genomebc.ca/news-events/event/applications-pacbio-single-molecule-real-time-smrt-dna-sequencing/?eID=28
Recent PACB News
- Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases • PR Newswire (US) • 05/15/2024 01:45:00 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 05/09/2024 08:33:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:21:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:12:15 PM
- PacBio Announces First Quarter 2024 Financial Results • PR Newswire (US) • 05/09/2024 08:05:00 PM
- PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance • PR Newswire (US) • 04/16/2024 12:05:00 PM
- Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes • PR Newswire (US) • 03/27/2024 12:00:00 PM
- PacBio Grants Equity Incentive Award to New Employee • PR Newswire (US) • 03/22/2024 08:30:00 PM
- PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions • PR Newswire (US) • 03/12/2024 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:36:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:30:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:26:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:22:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:32:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:22:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:55:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:36:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:25:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:19:42 PM
- PacBio to Present at Upcoming Investor Conferences • PR Newswire (US) • 02/26/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:25:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:17:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:07:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 09:17:12 PM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM